Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum.

Pipperger L, Koske I, Wild N, Müllauer B, Krenn D, Stoiber H, Wollmann G, Kimpel J, von Laer D, Bánki Z.

J Virol. 2019 Aug 28;93(18). pii: e00567-19. doi: 10.1128/JVI.00567-19. Print 2019 Sep 15.

2.

Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment.

Koske I, Rössler A, Pipperger L, Petersson M, Barnstorf I, Kimpel J, Tripp CH, Stoitzner P, Bánki Z, von Laer D.

Int J Cancer. 2019 Oct 1;145(7):1958-1969. doi: 10.1002/ijc.32325. Epub 2019 Apr 29.

PMID:
30972741
3.

Active Human Complement Reduces the Zika Virus Load via Formation of the Membrane-Attack Complex.

Schiela B, Bernklau S, Malekshahi Z, Deutschmann D, Koske I, Banki Z, Thielens NM, Würzner R, Speth C, Weiss G, Stiasny K, Steinmann E, Stoiber H.

Front Immunol. 2018 Oct 17;9:2177. doi: 10.3389/fimmu.2018.02177. eCollection 2018.

4.

The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma.

Kimpel J, Urbiola C, Koske I, Tober R, Banki Z, Wollmann G, von Laer D.

Viruses. 2018 Mar 2;10(3). pii: E108. doi: 10.3390/v10030108.

5.

Outer membrane protein OlpA contributes to Moraxella catarrhalis serum resistance via interaction with factor H and the alternative pathway.

Bernhard S, Fleury C, Su YC, Zipfel PF, Koske I, Nordström T, Riesbeck K.

J Infect Dis. 2014 Oct 15;210(8):1306-10. doi: 10.1093/infdis/jiu241. Epub 2014 Apr 25.

PMID:
24771863

Supplemental Content

Support Center